tirzepatide blood pressure reduction Obesity treatment and hypertension management aren't two separate conversations anymore — see the outcomes from @easo_org 's 2026 conference data. #GLP1 #Semaglutide #Tirzepatide #ObesityMedicine #BloodPressure # Hypertension #CardiometabolicHealth Systolic blood pressure reduction with

Available from: Deanfield J, Verma S, Scirica BM, Kahn SE, Emerson SS, Ryan D et al (2024) Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

Rotate injection sites weekly to prevent lipohypertrophy

Losing 7-10% of body weight can significantly reduce liver fat, with studies showing a 5% weight loss improves insulin resistance while 10% can reverse liver fibrosis

Factors that slow weight loss Alcohol consumption

Exploring the pathogenesis of depression and potential antidepressants through the integration of reverse network pharmacology, molecular docking, and molecular dynamics